Researchers in Leeds say PMR is underdiagnosed and undertreated in the north of England.

For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is ...

Background: the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from ...

The list of medications covered by the Estonian Health Insurance Fund was expanded in January, with new additions including ...

March 12, 2012 — Diagnosis of polymyalgia rheumatica (PMR) has started to move from the realm of clinical intuition toward a more objective approach, after the release of provisional classification ...

Researchers at the NIHR Leeds Biomedical Research Centre (BRC) and the University of Leeds have led an innovative new project studying how to bridge the gap between patients with PMR (Polymyalgia ...